Your genes may hold the key to safer lung transplants

NCT ID NCT00457847

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

Primary graft dysfunction (PGD) is a serious lung injury that can happen shortly after a lung transplant. This study looks at the DNA of 1,150 lung transplant recipients to see if certain genetic variations make some people more likely to develop PGD. By identifying these genetic risk factors, researchers hope to better understand who is at risk and why.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If genetic risk factors are identified, doctors may one day screen patients before transplant to predict and prevent this serious complication.
What could go wrong
This is an observational genetic study, not a treatment trial. It may not find clear genetic links, and even if it does, translating that into prevention will take years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Primary Graft Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.